Kentucky Mom Sues Pfizer Over Child’s Zoloft Birth Defects
By Andrea Gressman
On January 10, 2013, another Zoloft birth defect lawsuit was filed against Pfizer by a Kentucky mother. The mother alleges in the lawsuit that her child was born with congenital birth defects that were caused by Zoloft, an antidepressant the plaintiff took during her pregnancy. Both Pfizer and J.B. Roerig & Company have been named as defendants. Zoloft received it approval from the United States Food and Drug Administration (FDA) in 1991 to treat depression. From there the FDA approval expanded to treat conditions like panic disorders and OCD. According to the Zoloft birth defect lawsuit, however, the FDA never approved the SSRI antidepressant to be used by women during pregnancy. However, there have been thousands of pregnant women who have received prescriptions for Zoloft and used the drug during while pregnant despite the significant risk of pregnancy side effects.
The Zoloft lawsuit claims that the plaintiff received her prescription for Zoloft during her pregnancy with her son. On February 26, 2007, he was born with severe congenital birth defects. He suffered from patent ductus arteriosus as well as other medical issues. Because of these severe side effects the boy had to undergo heart surgery as well as other serious medical treatments that were life-threatening in nature.
The mother alleges in the Zoloft lawsuit that Pfizer was aware of, or at least should have been aware of, the risk of Zoloft birth defects as early as 1996 – well before she received her prescription for the SSRI. That’s because studies had revealed the risk that Zoloft and other SSRI antidepressants caused severe side effects when taken during pregnancy. The studies had revealed that there were heart malformation and other abnormalities that could be caused by these drugs. The side effects were also linked to extensive hospital stays, lower birth rates, lower gestational age, as well as APGAR scores that were lower in comparison to other control groups that involved mothers who did not take SSRI antidepressants during their pregnancies.
The birth defects lawsuit also claims Pfizer provided false information by exaggerating the negative side effects of Zoloft if the user discontinued its use during pregnancy. According to Pfizer, the risks associated with stopping Zoloft were greater than the risks the drug could cause to the fetus, which the lawsuit claims is untrue.
The mother alleges in the lawsuit that her child’s birth defects were the direct result of the way Pfizer fraudulently misrepresented Zoloft and the company’s failure to properly warn the plaintiff of the risks of Zoloft birth defects.
Despite a growing number of Zoloft side effect victims and an increase in birth defect lawsuits being filed as a result, there still has not been a recall for Zoloft. Zoloft is currently classified with the FDA as a Category C medication when it comes to its pregnancy risk. However, it is the hope of many side effect victims that the FDA will reclassify this as a Category D to provide additional warning to those who may potentially use the drug while pregnant.
If you have a child with a birth defect due to taking Zoloft during your pregnancy it is important to contact a qualified Zoloft birth defect attorney today to learn more about your legal rights.
Visit the Zoloft, Paxil, Celexa, Lexapro & Prozac SSRI Antidepressant Birth Defect Class Action Lawsuit Investigation page right away where you can provide your information and receive a free legal review with an experienced Zoloft lawyer.
Updated February 1st, 2013
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
2 thoughts onKentucky Mom Sues Pfizer Over Child’s Zoloft Birth Defects